Lakshya Pharma Profile
Key Indicators
- Authorised Capital ₹ 4.00 M
as on 12-12-2024
- Paid Up Capital ₹ 3.37 M
as on 12-12-2024
- Company Age 14 Year, 9 Months
- Last Filing with ROC 31 Mar 2021
- Open Charges ₹ 4.39 Cr
as on 12-12-2024
- Satisfied Charges ₹ 5.00 M
as on 12-12-2024
- Revenue 2.45%
(FY 2020)
- Profit -1.31%
(FY 2020)
- Ebitda -1.56%
(FY 2020)
- Net Worth 61.10%
(FY 2020)
- Total Assets 35.47%
(FY 2020)
About Lakshya Pharma
The Corporate was formerly known as Lakshya Remedies Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 4.00 M and a paid-up capital of Rs 3.37 M.
The company currently has active open charges totaling ₹4.39 Cr. The company has closed loans amounting to ₹5.00 M, as per Ministry of Corporate Affairs (MCA) records.
Anand Aspathi, Jithender Aspathi, Vijayalaxmi Arakala, and Three other members serve as directors at the Company.
- CIN/LLPIN
U24100TG2010PTC067177
- Company No.
067177
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Feb 2010
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Rangareddy, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Lakshya Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jithender Aspathi  | Managing Director | 23-Feb-2010 | Current |
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Anand Aspathi | Director | 29-Nov-2010 | Current |
| Vijayalaxmi Arakala | Director | 29-Nov-2010 | Current |
| Lakshmi Aspathi | Director | 06-Jun-2011 | Current |
| Goverdhan Arakala | Director | 25-Feb-2017 | Current |
| Padmavathi Aspathi | Director | 25-Feb-2017 | Current |
Financial Performance of Lakshya Pharma.
Lakshya Pharma Private Limited, for the financial year ended 2020, experienced modest growth in revenue, with a 2.45% increase. The company also saw a slight decrease in profitability, with a 1.31% decrease in profit. The company's net worth Soared by an impressive increase of 61.1%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Lakshya Pharma?
In 2019, Lakshya Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Gayathri Techno Solutions Private LimitedActive 7 months 29 days
Vijayalaxmi Arakala and Goverdhan Arakala are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Tata Capital Housing Finance Limited Creation Date: 14 Dec 2018 | ₹9.90 M | Open |
Hdfc Bank Limited Creation Date: 23 Mar 2017 | ₹3.40 Cr | Open |
Ing Vysya Bank Limited Creation Date: 29 Dec 2010 | ₹5.00 M | Satisfied |
How Many Employees Work at Lakshya Pharma?
Lakshya Pharma has a workforce of 98 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Lakshya Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lakshya Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
